Research & Development: Page 84
-
PharmaVoice Team/PharmaVoice
Strengthening the Clinical Recruitment Chain
W finding the right population within the right time frame means doing your homework, looking at feasibility data, modeling time frames, metrics, and budget parameters.” Negative press is another uncontrollable factor that can slow patient enrollment, par ticularly if a drug is pulled from the ma...
By Robin Robinson • Feb. 26, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
DETAILING DUDS Rep Access Continues to Fall Based on a comprehensive telephone survey of 180,000 doctors, almost one fifth of U.S. officebased physicians refuse to see sales representatives from the drug and device industry at any time, according to SK&A Information Services. Another 22.7% of...
By PharmaVoice Team • Feb. 26, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Letter from the Editor
It may not be Jules Verne’s rendition of “Around the World in 80 days,” but for many pharmaceutical company managers it’s time to brush up on their language skills and make sure their passports are in order. The world is definitely getting smaller. Companies that were once aligned as being multin...
By Taren Grom • Feb. 26, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Michael Naimoli is U.S. Life Sciences Industry Solutions Director for Microsoft, and he has extensive insight into the challenges the industry faces with regard to document regulation and submission management as well as other quality control and business challenges. Before joining Microsoft, Mr....
By PharmaVoice Team • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Michael E. KAMARCK Dr. Michael D. KOWOLENKO Joseph M. MAHADY Cavan M.REDMOND Douglas A. ROGERS Wyeth Hires and Promotes Executives Wyeth, Madison, N.J., has announced a number of executive hires and promotions at its pharmaceuticals and consumer health divisions. At Wyeth Pharmace...
By PharmaVoice Team • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
February 19 5th Annual Headache Research Summit Scottsdale,Ariz. For more information, contact National Headache Foundation, via email [email protected], or visit headaches.org. February 1921 Marketing Pharmaceuticals in aTime of Change NewYork Marriott Marquis Hotel,NewYork For more information...
By PharmaVoice Team • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Octagon Research Solutions Inc. has unveiled ViewPoint for Document Management, a solution that com bines existing Octagon document management, authoring tem plates, and document standards in a preconfigured environment designed to...
By PharmaVoice Team • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
What's New
NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Medical Simulation Corp (MSC) has introduced the SimSuite Collegiate Sales Force Training Program to help organizations provide their salesforces with the clinical competence and cred ibility needed to engage physicians beyond the sales scri...
By PharmaVoice Team • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
Managing Investigator Initiated Trials
Investigator initiated trials (IITs) can be a valuable part of a pharmaceutical or medical device manufacturer’s marketing claims arsenal, according to Rita Numerof, Ph.D., president, and Mark Morgan, M.S., senior business analyst, at Numerof & Associates Inc. The two contend that IITs are re...
By PharmaVoice Team • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
Conquering the Divide — Joseph Pieroni
BY KIM RIBBINK Drawn initially to the lab as a medicinal chemist,then to the business side of pharma research, Joseph P. Pieroni has been able to straddle the often divided worlds of research and marketing seamlessly. This combination of skills and interests is great news for Daiichi Sankyo Inc.,...
By Kim Ribbink • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
Super Bugs
Bacteria have proven to be resourceful organisms. They are so resourceful that the widespread use of antibiotics in recent years has enabled bacteria to adapt and develop resistance to currently marketed treatments. Antibiotics stop infection and the spread of infection, yet they also eventually ...
By Cynthia Borda • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
MSLs: Evolution of Skills
The intent of the first MSL role, created in 1967 by the Upjohn Company, was to create a position within the pharmaceutical company that could interact with academiabased physicians and researchers. In the 1970s, the trend grew, with other companies mostly implementing MSL hir ing from within the...
By Robin Robinson • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
Gene Therapy Research Makes Progress
With all the progress that has been made in genomics, targeting therapies to correct the defective genes responsible for disease seems quite realistic. But developing commercial gene therapies to treat diseases through modifying the expressions of an individual’s genes or correcting abnormal gene...
By Denise Myshko • Jan. 29, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
THE PRICE IS RIGHT Drug Pricing Decisions More Critical Than Ever In aneraofmore competition from generics, expiring patent protection for many topselling drugs, and a slowdown in new drug discoveries, there is very little margin for error in drug pricing decisions. Kalorama Information’s recent ...
By PharmaVoice Team • Jan. 29, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Wh o w o u l d h a v e thought that in 10 short years, we would have gone from Dolly to Elsie? In February 1997, scientists in Scotland announced the birth of the world’s first successfully cloned mammal, Dolly the sheep. Dolly, which was created at the Roslin Institute in Edinburgh, was actually...
By Taren Grom • Jan. 29, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive Appointments and Promotions Pharma POOL Dr. Corey Goodman Dr. Martin Mackay Dr. Briggs Morrison Pfizer Announces Executive Changes Pfizer has launched an independent, stand-alone biotherapeutics and bioinnovation center under the direction of scientist and entrepreneur Corey Goodman, Ph...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Internationally renowned vaccines, immunology, and virology expert Paul A. Offit, M.D., has dedicated his career to discovering vaccines to prevent infectious diseases, and is the co-inventor of the rotavirus vaccine, RotaTeq, developed by Merck. A pediatrician, author, and scientific researcher,...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Thomson Scientific Offers Data Platform for Researchers Thomson Scientific has released BONDplus, an integrated, Web-based data platform designed to deliver real-time, comprehensive public and proprietary biological sequence, inte...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies inVentiv Health Creates Patient Outcomes Segment New division combines capabilities that help patients achieve optimum health. inVentiv Health has launched inVentiv Patient Outcomes, a business segment focused on helping pharmaceutical comp...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Industry Events January 2008 January 15-16 2nd Annual Medical Science Liaison Skill Set Training Doubletree Hotel Philadelphia, Philadelphia For more information, contact Andrea Chadis, Center for Business Intelligence, at 781-939-2428, e-mail [email protected], or visit cbinet.com. January 15-...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Pharmacists Could Impact $145 Billion in Drug Sales in Five Years One state, Florida, already allows pharmacists to independently prescribe prescription drugs, and new research suggests six other states may soon give pharmacists this pow...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
When the Stars Align
By Robin Robinson The practice of using celebrities in marketing campaigns has not lost its luster, but the pharma industry is more selective in choosing icons who match brand images. As the industry approaches the 10th anniversary of the FDA’s ruling to allow DTC and subsequently the industry’s ...
By Robin Robinson • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Human Resource Related Issues
Otuska America Pharmaceutical’s Lorraine Daly, Leslie Eggleston, and Richard Obring discuss how HR issues, including compliance, compensation, and staffing can impact a pharmaceutical company’s culture. Otsuka’s Human Resources Department is responsible for more than 600 Otsuka employees in the U...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Craig A. DeLarge Craig A. DeLarge discusses Web 2.0’s drawbacks and opportunities. January 2008 Web 2.0 — Opportunities and Drawbacks n the last month, I have been intensely researching the Web 2.0 phenomenon with respect to its healthcare manifestations. This research has involved...
By Craig A. DeLarge • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Finding the Right Path -- Jane Hollingsworth
NuPathe cofounder and CEO Jane Hollingsworth has a fearless attitude about the risks involved in starting and running a business — and defines what it means to be an entrepreneur. Competitive by nature and with a fearless attitude when it comes to the risks involved in starting and running a busi...
By Kim Ribbink • Jan. 2, 2008
Previous
